John West, general manager of Illumina's DNA sequencing business unit and Kevin McKernan, an inventor of the Applied Biosystem's SOLiD System technology, both say their companies are playing with ...

Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

DNA can last for many centuries. A new DNA storage technology works in the laboratory with parallelizable writing processes ...

Illumina to release new version of its flagship cancer research assay, TruSight Oncology 500 v2: San Diego Thursday, November 21, 2024, 16:00 Hrs [IST] Illumina, Inc., a global le ...

The Invitrogen Collibri DNA Library Prep Kits prepare libraries for whole-genome sequencing (WGS) on Illumina NGS systems and contain tracking dyes to quickly and easily visualize library prep ...

Report on how AI is driving market transformation - The global DNA sequencing market size is estimated to grow by USD 17.34 ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will release TruSight™ Oncology 500 v2 (TSO 500 v2), a new version of its ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will ...